Events All Events

Paul Bleicher is an investor, consultant and advisor to healthcare and life science businesses, internationally. He participates in private equity investments in healthcare and life science IT/data as an executive partner at Ardan Equity and with startup companies through his work as a Founding Pillar at Pillar.

Prior to these roles, he was the chief executive officer of OptumLabs, an open, collaborative research and innovation center founded by Optum and Mayo Clinic to accelerate improvements in patient care and value through clinical, policy and product innovation driven by new insights from big data.

Before OptumLabs, he was chief medical officer and a member of the Board of Directors of Humedica, a next-generation clinical informatics company that was acquired by Optum in January 2013. Before Humedica, Dr. Bleicher was a founder and original CEO of Phase Forward, a company which pioneered the development of web-based electronic data capture for clinical trials and was acquired by Oracle Corporation in 2010. He had previously led clinical development at a biotechnology company (Alpha-Beta Technology), and began his career in industry at PAREXEL, where he assisted pharmaceutical and biotechnology companies with the clinical development of novel therapies.

Dr. Bleicher earned his BS from Rensselaer Polytechnic Institute and an MD/PhD from the University of Rochester School of Medicine and Dentistry. He trained in internal medicine at the Beth Israel Hospital, in dermatology at Harvard Medical School/Massachusetts General Hospital, and was a post-doctoral fellow at the Dana Farber Cancer Institute in molecular biology before beginning his career as an assistant professor at the Massachusetts General Hospital and Harvard Medical School. He has held various leadership positions and has received numerous awards for entrepreneurship and leadership in the pharmaceutical and health care industries.